Microbiota-derived metabolite promotes HDAC3 activity in the gut

Shu-en Wu(Cincinnati Children's Hospital Medical Center), Theresa Alenghat(Cincinnati Children's Hospital Medical Center), Rebekah Karns(Biomedical Informatics Research Center Antwerp), Lee A. Denson(Cincinnati Children's Hospital Medical Center), Emily M. Eshleman(Cincinnati Children's Hospital Medical Center), Seika Hashimoto‐Hill(Purdue University West Lafayette), Laura Engleman(Cincinnati Children's Hospital Medical Center), Vivienne Woo(Cincinnati Children's Hospital Medical Center), Jordan Whitt(Cincinnati Children's Hospital Medical Center), David Haslam(Cincinnati Children's Hospital Medical Center)
Nature
July 30, 2020
10.1038/s41586-020-2604-2
Cited by 254

Related Papers

The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47
|Nature Genetics|2011|1.4k
Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy
|Cell|2019|902
Respiratory epithelial cells orchestrate pulmonary innate immunity
|Nature Immunology|2014|764
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
|The Lancet|2017|647